Valo Health Expands Global Operations With Key Leadership in Tel Aviv

BOSTON, Dec. 9, 2020 /​PRNewswire/​— Valo Health LLC (Valo), the tech­nol­o­gy com­pa­ny aim­ing to trans­form the drug dis­cov­ery and devel­op­ment busi­ness, today announced they hired health-tech expert Maya Adu­lamy, who will be based out of Tel Aviv, Israel, to lead the com­pa­ny’s strate­gic partnerships.

As Exec­u­tive Direc­tor of Inno­va­tion and Head of Israel, Adu­lamy will play a key glob­al busi­ness devel­op­ment role, while work­ing close­ly with the extra­or­di­nary Israeli health­care and tech­nol­o­gy ecosystem.

“We tremen­dous­ly val­ue the pio­neer­ing approach to health­care and tech­nol­o­gy inno­va­tion in Israel, which is why we are com­mit­ted to con­tin­u­ing to build our pres­ence and rela­tion­ships there,” said Val­o’s Chief Inno­va­tion Offi­cer, Brett Black­man, Ph.D. ​“Maya’s exten­sive expe­ri­ence in cre­at­ing local and glob­al part­ner­ships in the heart of Israel will be invalu­able as we work to rev­o­lu­tion­ize the drug devel­op­ment process,” Black­man added.

“The work that Valo is doing towards accel­er­at­ing the cre­ation of life-chang­ing ther­a­peu­tics is unpar­al­leled, which is why I am thrilled to lead their efforts to estab­lish a greater pres­ence in Israel,” said Maya Adu­lamy. ​“There is obvi­ous­ly no short­age of inno­va­tion in Israel, a coun­try that has tak­en a clear lead­er­ship posi­tion at the fron­tier of med­i­cine. There is an unprece­dent­ed oppor­tu­ni­ty to work with Israel’s cut­ting-edge health-tech ecosys­tem in our shared vision to deliv­er mean­ing­ful cures to patients,” Adu­lamy added.

Adu­lamy joins Valo from the Kahn Sagol Mac­cabi Research and Inno­va­tion Cen­ter at Mac­cabi, the sec­ond largest HMO in Israel, where she served as the Chief Busi­ness Offi­cer, cre­at­ing med­ical data-based part­ner­ships with star­tups, researchers, and glob­al cor­po­ra­tions. Pri­or to that, Adu­lamy found­ed and man­aged the Nation­al Open Data pro­gram at the Israeli Prime Min­is­ter’s office and was the Israeli gov­ern­ment rep­re­sen­ta­tive to sev­er­al inter­na­tion­al orga­ni­za­tions. Adu­lamy also worked as a Par­lia­men­tary Advi­sor and com­plet­ed her legal train­ing with the State Attor­ney of Israel. She holds an LL.B in Law from the Hebrew Uni­ver­si­ty and an MBA from INSEAD, France.

About Valo
Valo Health, LLC (Valo) is using human-cen­tric data and machine learn­ing-anchored com­pu­ta­tion to trans­form the drug dis­cov­ery and devel­op­ment process. By inte­grat­ing data across the drug devel­op­ment life­cy­cle, the dis­cov­ery and devel­op­ment of life-chang­ing treat­ments can be accel­er­at­ed, with the poten­tial to reduce cost, time, and fail­ure rate. The com­pa­ny’s Opal Com­pu­ta­tion­al Plat­form™, a ful­ly inte­grat­ed, com­po­nen­tized, end-to-end drug devel­op­ment plat­form, offers a unique approach to ther­a­peu­tic devel­op­ment, that enables Valo to advance a robust pipeline of can­di­dates across car­dio­vas­cu­lar dis­ease, oncol­o­gy, and neu­rode­gen­er­a­tion. Head­quar­tered in Boston, MA, Valo has offices in Water­town, MA, San Fran­cis­co, CA, Prince­ton, NJ, and in Bran­ford, CT. To learn more, vis­it www​.val​o​health​.com.